Jennifer Effie Amengual, MD, detailed a clinical trial evaluating the dual epigenetic combination of tazemetostat and belinostat for the treatment of T-cell lymphomas.
Jennifer Effie Amengual, MD
Advertisement
Articles by Jennifer Effie Amengual, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Palbociclib Combo in HR+, HER2+ Metastatic Breast Cancer
2
Sacituzumab Govitecan Receives FDA Approval Across 2 TNBC Indications
3
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
4
EU Approves Enfortumab Vedotin/Pembrolizumab in Cisplatin-Ineligible MIBC
5